MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a progressive and irreversible neurodegenerative disorder, characterized by cognitive deficits and microscopic brain changes such as beta-amyloid plaques (Aβ plaques) outside neurons and twisted strands of the protein tau (tangles) inside neurons, and the latter two start being produced long before memory loss [1,2].